RGEN
Repligen Corp
Price:  
140.79 
USD
Volume:  
1,122,092.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-82.1%
Upside

As of 2024-07-27, the Relative Valuation of Repligen Corp (RGEN) is 25.14 USD. This relative valuation is based on P/E multiples. With the latest stock price at 140.79 USD, the upside of Repligen Corp based on Relative Valuation is -82.1%.

The range of the Relative Valuation is 8.51 - 42.43 USD.

Range Selected
Trailing P/E multiples 31.9x - 39.0x 35.3x
Forward P/E multiples 31.9x - 35.5x 34.2x
Fair Price 8.51 - 42.43 25.14
Upside -94.0% - -69.9% -82.1%
140.79 USD
Stock Price
25.14 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2024-07-26 527.80
2024-07-25 496.19
2024-07-24 492.56
2024-07-23 497.39
2024-07-22 485.77
2024-07-19 464.14
2024-07-18 478.46
2024-07-17 496.01
2024-07-16 506.09
2024-07-15 459.61
2024-07-12 472.05
2024-07-11 472.99
2024-07-10 453.42
2024-07-09 452.93
2024-07-08 449.07
2024-07-05 450.16
2024-07-03 452.75
2024-07-02 450.38
2024-07-01 462.31
2024-06-28 472.58
2024-06-27 474.56
2024-06-26 476.10
2024-06-25 461.67
2024-06-24 463.54
2024-06-21 469.80
2024-06-20 449.86
2024-06-18 461.11
2024-06-17 466.17
2024-06-14 470.93
2024-06-13 472.13
2024-06-12 535.59
2024-06-11 527.38
2024-06-10 529.45
2024-06-07 546.50
2024-06-06 556.85
2024-06-05 564.95
2024-06-04 553.89
2024-06-03 563.64
2024-05-31 558.91
2024-05-30 555.50
2024-05-29 570.05
2024-05-28 587.63
2024-05-24 592.91
2024-05-23 595.24
2024-05-22 619.04
2024-05-21 625.66
2024-05-20 643.97
2024-05-17 644.57
2024-05-16 641.16
2024-05-15 659.91